Hypereosinophilic syndrome: Another face of janus?

Leukemia Research

Volumn 32, Issue 9, 2008, Pages 1483-1485

  Dahabreh, Issa J ^a   Giannouli, Stavroula ^a   Zoi, Cristine ^b   Zoi, Katerina ^b   Loukopoulos, Dimitrios ^b   Voulgarelis, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYANOCOBALAMIN; HYDROXYUREA; IMMUNOGLOBULIN E; INTERLEUKIN 12; JANUS KINASE 2; STEM CELL FACTOR; STEROID; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CELL GRANULE; CELL VACUOLE; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EOSINOPHILIC LEUKEMIA; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; LETTER; LEUKOCYTE COUNT; LUNG DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN MANIFESTATION; TREATMENT RESPONSE;

AGED; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROXYUREA; HYPEREOSINOPHILIC SYNDROME; JANUS KINASE 2; POINT MUTATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 43049166913     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.12.007     Document Type: Letter

References (8)

1. Chusid M.J., Dale D.C., West B.C., and Wolff S.M. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 (1975) 1-27
2. Tefferi A., Patnaik M.M., and Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 133 (2006) 468-492
3. Dahabreh I.J., Giannouli S., Zoi C., Zoi K., Voulgarelis M., and Moutsopoulos H.M. Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics. Medicine (Baltimore) 86 (2007) 344-354
4. Sotlar K., Marafioti T., Griesser H., Theil J., Aepinus C., Jaussi R., et al. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Mol Pathol 53 (2000) 188-193
5. Simon H.U., Plotz S.G., Dummer R., and Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 (1999) 1112-1120
6. Jones A.V., Kreil S., Zoi K., Waghorn K., Curtis C., Zhang L., et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106 (2005) 2162-2168
7. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 (2003) 1201-1214
8. Steensma D.P., Dewald G.W., Lasho T.L., Powell H.L., McClure R.F., Levine R.L., et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes. Blood 106 (2005) 1207-1209